CBD has long been recognized as a solution to various ailments. It can be used for sleeping disorders, treating seizures, managing pain and increasing appetite loss – as well as potentially lessening cancer symptoms and other diseases.
A 10-panel drug test can detect drugs and their metabolites in urine, hair, saliva, blood, umbilical cord and sweat from urine samples collected over 24 hours. These include amphetamines (MAMP and MDMA-Ecstasy), cocaine, opiates such as heroin (heroin codeine and morphine), benzodiazepines and phencyclidine PCP.
It’s not a drug
CBD products are typically sold in oils, tinctures, capsules and inhalers. Although some contain trace amounts of THC, even one dose won’t produce a positive drug test result. The Drug Enforcement Agency classifies CBD as Schedule I substance; thus legal sales require a valid valid prescription; so it is crucial that consumers select high-quality products when shopping.
Consumers should take great care in selecting products containing no traces of THC and understand how the medicine interacts with other medications they are currently taking, including those prescribed to treat seizures or potentially cause seizures. CBD may inhibit their breakdown, leading to false positive drug screening results or false-positive test results.
Importantly, only Sativex has been approved by the FDA as a CBD product; most other CBD products have not undergone formal tests and could therefore not be suitable for consumption – especially edibles and oils. Therefore, it would be prudent to choose an isolate product when shopping for CBD-related items.
It’s a supplement
CBD, or cannabidiol, is an all-natural compound which has been shown to effectively relieve anxiety, chronic pain and sleep disorders. Studies have also demonstrated its efficacy at helping reduce opioid usage while improving insomnia symptoms. But there are some key points when using CBD; firstly it is not FDA regulated so it’s difficult to know exactly what you are getting, while some products make therapeutic claims without FDA clinical trial approval, potentially violating federal laws and placing patients at risk.
Issues arise because urine drug tests search for THC metabolites rather than actual compounds; this poses a threat for individuals taking CBD regularly or at high doses; furthermore, CBD may interfere with certain medicines like blood thinners that need to be broken down by liver.
It’s not a medication
Pure CBD (cannabidiol), with only trace amounts of THC, should not show up in standard drug tests; however, you should always read your product label to make sure it’s safe; many companies sell unpure products that have never undergone formal testing – making unsupported health claims.
Some CBD products contain high concentrations of THC, which may result in a positive urinalysis test result. A positive test result typically means that THC or its metabolites were consumed prior to taking the test; urinalysis is a urine analysis test which detects drugs present in your system.
CBD may interact with medications for blood thinners or those that affect liver enzymes, seizure and pain relief medication, seizure prevention medications and analgesia drugs – it’s best to stop taking any of them a few weeks prior to drug screenings for optimal results.
It’s not FDA-regulated
CBD products are not subject to FDA regulation, making their benefits and risks unknown. Furthermore, since CBD has not been FDA-approved to treat any specific health condition or make any health claims about itself; manufacturers cannot make these. Furthermore, most CBD products do not undergo quality or safety testing at the factory – with only Epidiolex being FDA-approved for treating epilepsy; therefore it’s crucial that you purchase from reliable manufacturers only.
Workplace drug tests typically screen for THC, the psychoactive component of marijuana. 5-panel and 10-panel drug tests typically detect THCCOOH metabolites found in urine samples to identify whether someone may contain any. Although it’s unlikely, CBD may give rise to positive test results.
Absent FDA oversight, it is possible that some CBD products contain trace amounts of THC – especially less-reputable brands. Furthermore, cross-contamination and mislabeling during production could result in false positive workplace drug tests; certain medications could alter these test results, including dronabinol, NSAIDs, pantoprazole and efavirenz.